Replimune Group Inc (REPL) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Replimune Group Inc   (NASDAQ: REPL)


Replimune Group Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Replimune Group Inc's ROI in the first quarter of 2026?
Replimune Group Inc recorded a cumulative net loss of $-297 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -88.35%.

Within the Healthcare sector 135 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 4359 to 4375.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM -25.32 % -18.48 % -6.7 % -16.44 % -13.51 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 214 305 489 337 410
Return On Investment (TTM) -88.35 % -81.51 % -73.03 % -73.75 % -62.25 %
REPL's Overall Ranking # 4375 # 4359 # 273 # 3404 # 3115
Seq. Investment Change TTM -12.72 % -10.66 % 2.48 % -6.55 % -4.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -297 -314 -315 -310 -280

REPL Company Profile >> Back to REPL Roi Comparisons >> See Annual REPL Return On Investment



Return On Investment REPL's Ranking
Within: No.
Industry # 13
Sector # 136
Overall # 4375

Return On Investment Statistics
High Average Low
-7.64 %
-38.64 %
-88.35 %
(Jun 30 2020)   (Jun 30 2026)







Financial Statements
Replimune Group Inc's I. Quarter Investments $ 214 Millions REPL's Balance sheet
Replimune Group Inc's I. Quarter Income $ -70 Millions Quarterly REPL's Income Statement
REPL's Income by Division See REPL's Income by Division


REPL Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 274 489 447 613 440
Y / Y Investment Growth -43.93 % 9.32 % -27.01 % 39.13 % -16.67 %
Net Income in Millions -314 -247 -216 -174 -118
Y / Y Net Income Growth - - - - -
Annual Return On Investment -114.51 % -50.58 % -48.25 % -28.44 % -26.8 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
REPL's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for REPL's Competitors
Subscribers only: Roi for Replimune Group Inc's Suppliers
Subscribers only: Return On Investment for REPL's Customers

Other Ratios
REPL's Roa REPL's Inventory Turnover Ratio REPL's Growth Rates REPL's Dividend Statistics
REPL's Profitability Ratios REPL's Asset Turnover Ratio REPL's Dividend Growth
REPL's Roe REPL's Valuation Ratios REPL's Financial Strength Ratios REPL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-15T21:41:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.